A significant breakthrough in cancer study is arising with the use of VHH fragments to re-engage damaged p53. This vital malignant inhibitor protein is frequently lost in many forms of cancer, resulting uncontrolled https://indexedbookmarks.com/story21850341/nanobodies-reactivate-the-p53-protein-a-new-approach-for-tumor-treatment